BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3098915)

  • 21. Correlation of hepatitis B surface antigen clearance with the route of hepatitis B virus infection.
    Tassopoulos NC; Papaevangelou GJ
    J Gastroenterol Hepatol; 1990; 5(3):252-5. PubMed ID: 2103406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
    J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Delta agent infection and immunoglobulin G in acute HBsAg-positive hepatitis with chronic course].
    Tagariello G; Pasquinucci S; Belussi F; Dal Canton A; Alberti A
    Boll Ist Sieroter Milan; 1987; 66(6):485-8. PubMed ID: 3453151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.
    Gerlich WH; Uy A; Lambrecht F; Thomssen R
    J Clin Microbiol; 1986 Aug; 24(2):288-93. PubMed ID: 3745425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HBV carriers and HDV superinfection--studies on the cases of HBsAg clearance].
    Tamura I; Ichimura H; Tsubakio T; Kurimura O; Kurimura T
    Kansenshogaku Zasshi; 1989 Feb; 63(2):103-8. PubMed ID: 2501426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM anti-HBc in acute and chronic hepatitis B virus (HBV) infection: diagnostic value and correlation with viral replication and disease activity.
    Craxì A; Marino L; Aragona E; Patti C
    Boll Ist Sieroter Milan; 1988; 67(4):275-82. PubMed ID: 3078240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The serology of delta hepatitis and the detection of IgM anti-HD by EIA using serum derived delta antigen.
    Shattock AG; Morris M; Kinane K; Fagan C
    J Virol Methods; 1989 Mar; 23(3):233-40. PubMed ID: 2654168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic significance of anti-HBcIgM prevalence related to symptoms in Canadian patients acutely or chronically infected with hepatitis B virus.
    Chernesky M; Mahony J; Castriciano S; Sekla L; Bishai F; Vas S
    J Med Virol; 1986 Nov; 20(3):269-77. PubMed ID: 3537207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fulminant hepatitis due to HBV/HDV coinfection.
    Koff RS
    Hosp Pract (Off Ed); 1987 Nov; 22(11):123-30, 139-40, 145-50 passim. PubMed ID: 3119612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-HBc IgM in acute and chronic hepatitis B virus infection].
    Gmelin K; Theilmann L; Hasche G; Will H; Czygan P; Doerr HW; Kommerell B
    Klin Wochenschr; 1984 Sep; 62(17):837-42. PubMed ID: 6482320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey.
    Balik I; Onul M; Tekeli E; Caredda F
    Eur J Epidemiol; 1991 Jan; 7(1):48-54. PubMed ID: 2026223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B.
    Chu CM; Sheen IS; Liaw YF
    Gastroenterology; 1994 Jul; 107(1):189-95. PubMed ID: 8020661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological diagnosis of hepatitis B and delta virus (HBV/HDV) coinfection.
    Salassa B; Daziano E; Bonino F; Lavarini C; Smedile A; Chiaberge E; Rosina F; Brunetto MR; Pessione E; Spezia C
    J Hepatol; 1991 Jan; 12(1):10-3. PubMed ID: 2007765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis.
    Lavarini C; Farci P; Chiaberge E; Veglio V; Giacobbi D; Bedarida G; Susani G; Toti M; Almi P; Caporaso N
    Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1254-6. PubMed ID: 6416354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the response time of anti-HBc IgM in a hepatitis B case load. Diagnostic implications].
    Cremoni L; Buffa D; Sauco F; Bongetta R; Arosio M; d'Amico P
    Boll Ist Sieroter Milan; 1986; 65(5):430-5. PubMed ID: 3828097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of circulating HBsAg in acute hepatitis B.
    Fasel-Felley J; Peitrequin R; Frei PC
    Infection; 1984; 12(3):202-4. PubMed ID: 6469366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of hepatitis delta virus superinfection on the clearance of hepatitis B virus (HBV) markers in HBV carriers in Japan.
    Ichimura H; Tamura I; Tsubakio T; Kurimura O; Kurimura T
    J Med Virol; 1988 Sep; 26(1):49-55. PubMed ID: 3183634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
    Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
    J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.
    di Filippo Villa D; Cortes-Mancera F; Payares E; Montes N; de la Hoz F; Arbelaez MP; Correa G; Navas MC
    Virol J; 2015 Oct; 12():172. PubMed ID: 26497287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.